Theralase Technologies Inc. V.TLT

CG0070 + Pembrolizumab...Not even close to TLT-Ruvidar.

[wildbird1]

I am still on my holiday break, but could not resist to give my point of view on CG0070+Pembrolizumab.

It never cease to amaze me how some posters do not take the time to research the treatment that they say will compete with TLT-Ruvidar.

In this link...
https://mayo.edu/research/clinical-trials/cls-20508002#eligibility

In this link under "Participation Eligibility", there is a small red box that say "show more eligibility criteria".
If you look at the "exclusion criteria".
You come to the conclusion that except for having BCG resistant bladder cancer, the patient in order to receive CG0070+Pembrolizumab has to be almost in perfect health.

In short ...
If TLT-Ruvidar was treating the same kind of patients as CG0070+Pembrolizumab(with the same exclusion criteria), TLT-Ruvidar could easily have a 80-90% CR over 12 months.You have to remember that TLT-Ruvidar treat all patients without restrictions and as a bonus has side effects.

I am going back on my holiday break(will be back in 2024 unless ???), for the posters that bring on these kind of false competitors to TLT-Ruvidar, please take the time to google it first.

[wildbird1]

A little typo error " has a bonus has no side effects"

[Infinity]

Excellent point Wildbird.  Enjoy your Holiday.  In addition, this study 1. Excludes immune  deficient patients. 2.  Patient must have all resectable tumor removed.  Meaning TURBT already done.

[TriumphSpitSix]

Amazingly, there's actually an "Edit" feature on Telegram so you an easily fix typos like this. Such a novel concept that 19th century era Shlockhouse doesn't seem to understand or care about. https://t.me/Theralase_Technologies_Chat

[tdon1229]

Or, you could do something even more basic and proofread before you hit "Post".

[Rumpl3StiltSkin]

Excelent post Birdy, I'll do the edit for you, go back on break. He meant to say 'no side effects'...  :-)

[StevenBirch]

Thanks Wildbird, some never take a vacation from being negative.

[DeathXray33]

@ > 1.212 million now... Have a wonderful weekend. See you next week...

[99942Apophis]

Thanks for your usual excellent research wildbird1 

[Sunvalley]

Excellent points wildbird1. Thank you for your astute" attention to detail" reporting. What we all should realize by now is that, in my opinion , Dumb is a little boy basher and is here to mislead and obfuscate even tho he claims to own a lot of shares. That claim , in my opinion , is just a trojan horse tactic so that he can gain some credibility that enables him to come here  to

[Dumbeldorfwhite]

Ya ‘ll keep sippin the look aid, 70%> 40% Having those exclusions sure didn't seem to hurt enrollment they got 100 patients wayyyyyyy faster. At the current enrollment rates u guys do realize it's going to take around 2 more years simply to have 100 people, then another 1.5 years to have all the data.  how is this company going to survive raising 1 million every other month?

[Oilminerdeluxe]

We are very aware of the slow enrollment. We do however have enough patients in the bag for FDA to make a decision. If they demand all 100, I am sure they will let us know.

[tdon1229]

Basic sampling theory...you need a certain sample size and a certain amount of successful results to be able to apply the results of the trial to the size of the population you expect to offer the treatment.  FDA has the sample sizes identified at its site.  Anyone with clinical trial experience or QA/QC sampling experience can fill you in or direct your to the pages.